Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost for Prevention of Contrast-Mediated Nephropathy
NCT00345501Phase 3Completed
- Sponsor
- Onassis Cardiac Surgery Center
- Start
- Nov 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of iloprost in contrast-induced nephropathy (CIN), sponsored by Onassis Cardiac Surgery Center. Started Nov 2005; status: completed.
02
Drugs
iloprost
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00345501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345501.